0.1000
0.0000
(0.00%)
As of 10:12:07 AM EDT. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,012.8090
--
156.7330
1,607.7750
1,341.5740
Cost of Revenue
1,019.2070
--
44.7040
1,039.3340
814.7150
Gross Profit
993.6020
--
112.0290
568.4410
526.8590
Operating Expense
5,154.2500
--
3,569.6340
5,451.9980
4,751.2320
Operating Income
-4,160.6480
--
-3,457.6050
-4,883.5570
-4,224.3730
Net Non Operating Interest Income Expense
-750.8400
--
-801.2010
-294.1280
-83.2560
Other Income Expense
0.6480
--
237.1680
327.7730
461.6530
Pretax Income
-4,910.8400
--
-4,021.6380
-4,849.9120
-3,845.9760
Net Income Common Stockholders
5,598.8140
--
-3,889.8920
-4,604.5660
-3,716.6860
Diluted NI Available to Com Stockholders
5,598.8140
--
-3,889.8920
-4,604.5660
-3,716.6860
Basic EPS
0.05
-0.04
-0.03
-0.04
-0.03
Diluted EPS
0.05
-0.04
-0.03
-0.04
-0.03
Basic Average Shares
132,474.9390
127,119.9570
120,702.0740
112,600.4200
108,613.5350
Diluted Average Shares
132,474.9390
127,119.9570
120,702.0740
112,600.4200
108,613.5350
Total Operating Income as Reported
-4,160.6480
--
-3,457.6050
-4,883.5570
-4,224.3730
Total Expenses
6,173.4570
--
3,614.3380
6,491.3320
5,565.9470
Net Income from Continuing & Discontinued Operation
5,598.8140
--
-3,889.8920
-4,604.5660
-3,716.6860
Normalized Income
-4,949.9730
--
-4,069.8000
-4,608.5410
-3,718.2860
Interest Income
7.1290
--
15.4630
121.9290
38.3000
Interest Expense
757.9690
--
816.6640
416.0570
121.5560
Net Interest Income
-750.8400
--
-801.2010
-294.1280
-83.2560
EBIT
-4,152.8710
--
-3,204.9740
-4,433.8550
-3,724.4200
EBITDA
-3,939.5460
--
-2,947.2920
-4,245.8850
-3,646.3110
Reconciled Cost of Revenue
1,019.2070
--
44.7040
1,039.3340
814.7150
Reconciled Depreciation
213.3250
--
257.6820
187.9700
78.1090
Net Income from Continuing Operation Net Minority Interest
-4,949.3250
--
-4,087.5300
-4,604.5660
-3,716.6860
Total Unusual Items Excluding Goodwill
0.6480
--
-17.7300
3.9750
1.6000
Total Unusual Items
0.6480
--
-17.7300
3.9750
1.6000
Normalized EBITDA
-3,940.1940
--
-2,929.5620
-4,249.8600
-3,647.9110
12/31/2020 - 10/1/2003
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IOT.V Innovotech Inc.
0.1400
0.00%
HBP.TO Helix BioPharma Corp.
0.7700
-2.53%
QPT.V Quest PharmaTech Inc.
0.0500
-9.09%
ONCO.CN Onco-Innova
1.6100
+3.87%
MBX.TO Microbix Biosystems Inc.
0.3450
-1.43%
OBIO Orchestra BioMed Holdings, Inc.
2.8900
+11.15%
HEM.V Hemostemix Inc.
0.0950
+5.56%
BNTC Benitec Biopharma Inc.
12.62
+5.70%
MIR.V MedMira Inc.
0.0950
+18.75%
NKTX Nkarta, Inc.
1.6250
+6.21%